We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

57 hedge funds and large institutions have $196M invested in Syneron Medical Ltd in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

9% more capital invested

Capital invested by funds: $180M → $196M (+$15.9M)

14% less funds holding

Funds holding: 66 → 57 (-9)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

89% less call options, than puts

Call options by funds: $2K | Put options by funds: $19K

Holders
57
Holders Change
-9
Holders Change %
-13.64%
% of All Funds
1.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
19
Reduced
16
Closed
17
Calls
$2K
Puts
$19K
Net Calls
-$17K
Net Calls Change
-$222K

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$11.5M
2
BIP
Brandes Investment Partners
California
+$8.96M
3
IAM
Ion Asset Management
Israel
+$5.4M
4
NTC
North Tide Capital
Massachusetts
+$3.81M
5
CAD
Craig A. Drill
+$2.81M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$14.9M
2
HC
Hourglass Capital
Texas
-$5.07M
3
PAIM
Punch & Associates Investment Management
Minnesota
-$3.46M
4
Norges Bank
Norges Bank
Norway
-$2.4M
5
JGC
J. Goldman & Co
New York
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Senvest Management
New York
$29.9M – – –
NTC
2
North Tide Capital
Massachusetts
$27M +$3.81M +500,000 +17%
JP Morgan Chase
3
JP Morgan Chase
New York
$21.9M +$219K +28,751 +1%
DGHMC
4
Dalton, Greiner, Hartman, Maher & Co
New York
$14M +$2.59M +339,282 +23%
BIP
5
Brandes Investment Partners
California
$13.5M +$8.96M +1,175,299 +206%
CCM
6
Camber Capital Management
Massachusetts
$11.6M +$11.5M +1,505,700 New
SAM
7
Senzar Asset Management
New York
$10.8M +$1.64M +214,772 +18%
IAM
8
Ion Asset Management
Israel
$9.27M +$5.4M +707,910 +143%
BC
9
Broadfin Capital
New York
$8.14M – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$6.94M -$92.8K -12,174 -1%
GIM
11
Granahan Investment Management
Massachusetts
$6.43M -$1.8M -235,931 -22%
Millennium Management
12
Millennium Management
New York
$5.3M -$618K -81,052 -11%
RA
13
Royce & Associates
New York
$5.11M +$341K +44,700 +7%
Deutsche Bank
14
Deutsche Bank
Germany
$4.12M +$189K +24,847 +5%
Ameriprise
15
Ameriprise
Minnesota
$4.1M +$852K +111,783 +27%
PCM
16
Perritt Capital Management
Illinois
$3.08M – – –
CAD
17
Craig A. Drill
$2.84M +$2.81M +368,820 New
LAM
18
Lapides Asset Management
Connecticut
$1.83M +$1.23M +161,200 +210%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.47M -$592K -77,671 -29%
USAA
20
United Services Automobile Association
Texas
$1.43M -$80.6K -10,570 -5%
BIM
21
Bogle Investment Management
Massachusetts
$833K +$284K +37,231 +53%
TA
22
Teton Advisors
New York
$781K – – –
GCP
23
GSA Capital Partners
United Kingdom
$778K +$309K +40,572 +67%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$772K -$42.7K -5,600 -5%
DCM
25
DAFNA Capital Management
California
$663K – – –
1
2 3

ELOS Hedge Fund Activity: Q4 2015 in Review

57 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2015, worth a combined $196M — up 8.8% from $180M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ELOS and 8 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 19 added.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $11.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.9M sold.

  • 57 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2015, down from 66 in Q3 2015.
  • Funds reported $196M of Syneron Medical Ltd stock for Q4 2015, up 8.8% quarter-over-quarter.
  • 8 funds opened new Syneron Medical Ltd positions in Q4 2015 and 17 closed out, a net change of -9 holders.
  • The largest Syneron Medical Ltd buyer in Q4 2015 was Camber Capital Management, an estimated $11.5M added.
  • The largest Syneron Medical Ltd seller in Q4 2015 was Deerfield Management, an estimated $14.9M sold.

Based on aggregated 13F filings for Q4 2015.